647 related articles for article (PubMed ID: 12405864)
41. [Drug metabolism in the septic liver: conclusions about the pharmacokinetics of chloramphenicol].
Jmelnitzky AC; Moday MC; Dana R; Flores C; Vitale A; Lauri IH
Acta Gastroenterol Latinoam; 1985; 15(1):33-42. PubMed ID: 4090920
[TBL] [Abstract][Full Text] [Related]
42. [The effect of cardiac insufficiency on pharmacokinetics].
Cheymol G; Jaillon P
Arch Mal Coeur Vaiss; 1989 Mar; 82(3):391-7. PubMed ID: 2502096
[TBL] [Abstract][Full Text] [Related]
43. Influence of N-acetylcysteine on indirect indicators of tissue oxygenation in septic shock patients: results from a prospective, randomized, double-blind study.
Spies CD; Reinhart K; Witt I; Meier-Hellmann A; Hannemann L; Bredle DL; Schaffartzik W
Crit Care Med; 1994 Nov; 22(11):1738-46. PubMed ID: 7956276
[TBL] [Abstract][Full Text] [Related]
44. Clinical pharmacokinetics in patients with liver disease.
McLean AJ; Morgan DJ
Clin Pharmacokinet; 1991 Jul; 21(1):42-69. PubMed ID: 1914341
[TBL] [Abstract][Full Text] [Related]
45. Emergency department antimicrobial considerations in severe sepsis.
Green RS; Gorman SK
Emerg Med Clin North Am; 2014 Nov; 32(4):835-49. PubMed ID: 25441038
[TBL] [Abstract][Full Text] [Related]
46. Sepsis-associated changes of the arachidonic acid metabolism and their diagnostic potential in septic patients.
Bruegel M; Ludwig U; Kleinhempel A; Petros S; Kortz L; Ceglarek U; Holdt LM; Thiery J; Fiedler GM
Crit Care Med; 2012 May; 40(5):1478-86. PubMed ID: 22511130
[TBL] [Abstract][Full Text] [Related]
47. Basic concepts of clinical pharmacokinetics.
Raghuram TC; Krishnaswamy K
J Assoc Physicians India; 1992 Jan; 40(1):29-35. PubMed ID: 1634460
[TBL] [Abstract][Full Text] [Related]
48. Pharmacokinetic drug interactions with nonsteroidal anti-inflammatory drugs.
Verbeeck RK
Clin Pharmacokinet; 1990 Jul; 19(1):44-66. PubMed ID: 2199127
[TBL] [Abstract][Full Text] [Related]
49. Depletion of high-affinity corticosteroid-binding globulin corresponds to illness severity in sepsis and septic shock; clinical implications.
Nenke MA; Rankin W; Chapman MJ; Stevens NE; Diener KR; Hayball JD; Lewis JG; Torpy DJ
Clin Endocrinol (Oxf); 2015 Jun; 82(6):801-7. PubMed ID: 25409953
[TBL] [Abstract][Full Text] [Related]
50. Antithrombin replacement in patients with sepsis and septic shock.
Giudici D; Baudo F; Palareti G; Ravizza A; Ridolfi L; D' Angelo A
Haematologica; 1999 May; 84(5):452-60. PubMed ID: 10329925
[TBL] [Abstract][Full Text] [Related]
51. [Is infection and septic shock caused by a global oxygen deficiency? An overview in 2 parts. 1: Infection and correlation between DO2 and VO2].
Ensinger H; Georgieff M
Anasthesiol Intensivmed Notfallmed Schmerzther; 1996 Apr; 31(3):132-42. PubMed ID: 8672614
[TBL] [Abstract][Full Text] [Related]
52. Disease-induced modifications of drug pharmacokinetics.
Barre J; Houin G; Brunner F; Bree F; Tillement JP
Int J Clin Pharmacol Res; 1983; 3(4):215-26. PubMed ID: 6381335
[TBL] [Abstract][Full Text] [Related]
53. Pharmacokinetics of oral fludrocortisone in septic shock.
Polito A; Hamitouche N; Ribot M; Polito A; Laviolle B; Bellissant E; Annane D; Alvarez JC
Br J Clin Pharmacol; 2016 Dec; 82(6):1509-1516. PubMed ID: 27416887
[TBL] [Abstract][Full Text] [Related]
54. [Characteristics of amino acid metabolism in patients with severe sepsis and septic shock].
Leĭderman IN; Rudnov VA; Logvinenko NN; Kogan EO
Anesteziol Reanimatol; 1997; (1):45-8. PubMed ID: 9173819
[TBL] [Abstract][Full Text] [Related]
55. Optimizing Pharmacokinetics-Pharmacodynamics of Antimicrobial Management in Patients with Sepsis: A Review.
Phe K; Heil EL; Tam VH
J Infect Dis; 2020 Jul; 222(Suppl 2):S132-S141. PubMed ID: 32691832
[TBL] [Abstract][Full Text] [Related]
56. The effects of exercise on the pharmacokinetics of drugs.
Khazaeinia T; Ramsey AA; Tam YK
J Pharm Pharm Sci; 2000; 3(3):292-302. PubMed ID: 11293389
[TBL] [Abstract][Full Text] [Related]
57. A paradigm shift in pharmacokinetic-pharmacodynamic (PKPD) modeling: rule of thumb for estimating free drug level in tissue compared with plasma to guide drug design.
Poulin P
J Pharm Sci; 2015 Jul; 104(7):2359-68. PubMed ID: 25943586
[TBL] [Abstract][Full Text] [Related]
58. Drug metabolism and ageing.
Wynne H
J Br Menopause Soc; 2005 Jun; 11(2):51-6. PubMed ID: 15970015
[TBL] [Abstract][Full Text] [Related]
59. Rules of anti-infection therapy for sepsis and septic shock.
Zhou X; Su LX; Zhang JH; Liu DW; Long Y
Chin Med J (Engl); 2019 Mar; 132(5):589-596. PubMed ID: 30807357
[TBL] [Abstract][Full Text] [Related]
60. Principles of drug biodisposition in the neonate. A critical evaluation of the pharmacokinetic-pharmacodynamic interface (Part I).
Besunder JB; Reed MD; Blumer JL
Clin Pharmacokinet; 1988 Apr; 14(4):189-216. PubMed ID: 3292100
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
